1. MiR-143 Inhibits Osteoclastogenesis by Targeting RANK and NF-κB and MAPK Signaling Pathways
   Xianfeng He et al, 2020, Current Molecular Pharmacology CrossRef
2. Therapeutic efficacy of soluble receptor activator of nuclear factor-κB-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma
   François Lamoureux et al, 2008, Molecular Cancer Therapeutics CrossRef
3. Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma
   Francois Lamoureux et al, 2009, Cancer Research CrossRef
4. Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption
   François Lamoureux et al, 2007, Cancer Research CrossRef